More Immutep Ltd news Immutep LtdASX: IMM 1st Patient Dosed in Phase 2 Soft Tissue Sarcoma Trial Jul 28, 2023 at 3:11 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
